145 related articles for article (PubMed ID: 9777789)
1. Rational design of receptor-selective retinoids.
Chandraratna RA
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S124-8. PubMed ID: 9777789
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
[TBL] [Abstract][Full Text] [Related]
3. Novel retinoids with receptor selectivity and functional selectivity.
Johnson A; Chandraratna RA
Br J Dermatol; 1999 Apr; 140 Suppl 54():12-7. PubMed ID: 10731129
[TBL] [Abstract][Full Text] [Related]
4. Receptor-selective retinoids for psoriasis: focus on tazarotene.
Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene--first of a new generation of receptor-selective retinoids.
Chandraratna RA
Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
[TBL] [Abstract][Full Text] [Related]
6. Developments in topical retinoid therapy for acne.
Bershad S
Semin Cutan Med Surg; 2001 Sep; 20(3):154-61. PubMed ID: 11594670
[TBL] [Abstract][Full Text] [Related]
7. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
Dando TM; Wellington K
Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
[TBL] [Abstract][Full Text] [Related]
8. Future trends: a new generation of retinoids.
Chandraratna RA
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S149-52. PubMed ID: 9777794
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
Roeder A; Schaller M; Schäfer-Korting M; Korting HC
Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
[TBL] [Abstract][Full Text] [Related]
10. Tazarotene in combination with phototherapy.
Koo JY
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.
DiSepio D; Ghosn C; Eckert RL; Deucher A; Robinson N; Duvic M; Chandraratna RA; Nagpal S
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14811-5. PubMed ID: 9843971
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of psoriasis and the mechanism of action of tazarotene.
Duvic M; Asano AT; Hager C; Mays S
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S129-33. PubMed ID: 9777790
[TBL] [Abstract][Full Text] [Related]
13. The role of tazarotene in the treatment of psoriasis.
Marks R
Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
15. Current research and future developments in retinoids: oral and topical agents.
Chandraratna RA
Cutis; 1998 Feb; 61(2 Suppl):40-5. PubMed ID: 9787993
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of tazarotene action in psoriasis.
Duvic M; Nagpal S; Asano AT; Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene in combination with topical corticosteroids.
Lebwohl M; Poulin Y
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety review of tazarotene.
Marks R
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid.
Behrens S; Grundmann-Kollmann M; Peter RU; Kerscher M
Br J Dermatol; 1999 Jul; 141(1):177. PubMed ID: 10417841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
